2 approved drugs show promise in treating prion disease

04/4/2013 | Yahoo

Researchers have found that two drugs already approved for use in humans -- tacrolimus and astemizole -- reduce the amount of prion protein present on cell surfaces by about 70%. Misfolded forms of the proteins are believed to cause such diseases as Creutzfeldt-Jakob disease. Astemizole is the most promising because it is effective at relatively low doses, while tacrolimus can cause neurotoxicity.

View Full Article in:

Yahoo

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Staff Quality Engineer
Teleflex
Durham, NC
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Vice President, Finance
VNSNY CHOICE
Manhattan, NY
Provider Payment Manager
UCare
Minneapolis, MN
Regulatory Affairs Specialist
Becton Dickinson
Franklin Lakes, NJ